Intracerebroventricular kainic acid administration to neonatal rats alters interneuron development in the hippocampus

Developmental Brain Research

Volumn 145, Issue 1, 2003, Pages 81-92

  Dong, Hongxin ^a   Csernansky, Cynthia A ^a   Chu, Yunxiang ^a   Csernansky, John G ^a  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Calbindin 28; GABA; GAD 67; Hippocampus; Interneuron; Kainic acid; Neurodevelopment; Parvalbumin; Schizophrenia

Indexed keywords

CALBINDIN; CELL MARKER; EXCITOTOXIN; GLUTAMATE DECARBOXYLASE; KAINIC ACID; PARVALBUMIN; AMINO ACID RECEPTOR STIMULATING AGENT; GLUTAMATE DECARBOXYLASE 67; ISOENZYME;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CELL COUNT; CONTROLLED STUDY; EXPERIMENTAL RAT; FEMALE; HIPPOCAMPUS; IMMUNOHISTOCHEMISTRY; INTERNEURON; NERVE CELL DIFFERENTIATION; NEWBORN; NISSL SUBSTANCE; NONHUMAN; PERINATAL PERIOD; PRIORITY JOURNAL; RAT; SCHIZOPHRENIA; STAINING; AGING; ANIMAL; COMPARATIVE STUDY; CYTOLOGY; DRUG EFFECT; INTRACEREBROVENTRICULAR DRUG ADMINISTRATION; MALE; METABOLISM; METHODOLOGY;

ANIMALIA;

AGING; ANIMALS; ANIMALS, NEWBORN; CALCIUM-BINDING PROTEIN, VITAMIN D-DEPENDENT; CELL COUNT; EXCITATORY AMINO ACID AGONISTS; FEMALE; GLUTAMATE DECARBOXYLASE; HIPPOCAMPUS; IMMUNOHISTOCHEMISTRY; INJECTIONS, INTRAVENTRICULAR; INTERNEURONS; ISOENZYMES; KAINIC ACID; MALE; PARVALBUMINS; RATS; STAINING AND LABELING;

EID: 1642347161     PISSN: 01653806     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0165-3806(03)00216-5     Document Type: Article

References (57)

1. Albala B.J., Moshe S.L., Okada R. Kainic acid-induced seizures: a developmental study. Dev. Brain Res. 13:1984;139-148.
2. Arnold S.E. Neurodevelopmental abnormalities in schizophrenia: insights from neuropathology. Dev. Psychopathol. 11:1999;439-456.
3. Baimbridge K.G., Celio M.R., Rogers J.H. Calcium-binding proteins in the nervous system. Trends Neurosci. 15:1992;303-308.
4. Belluardo N., Korhonen L., Mudo G., Lindholm D. Neuronal expression and regulation of rat inhibitor of apoptosis protein-2 by kainic acid in the rat brain. Eur. J. Neurosci. 15:2002;87-100.
5. Ben-Ari Y. Limbic seizure and brain damage produced by kainic acid: mechanisms and relevance to human temporal lobe epilepsy. Neuroscience. 14:1985;375-403.
6. Benes F.M., Vincent S.L., Alsterberg G., Bird E.D., SanGiovanni J.P. Increased GABAa receptor binding in superficial layers of cingulate cortex in schizophrenics. J. Neurosci. 12:1992;924-929.
7. Benes F.M., Kwok E.W., Vincent S.L., Todtenkopf M.S. A reduction of nonpyramidal cells in sector CA2 of schizophrenics and manic depression. Biol. Psychiatry. 44:1998;88-97.
8. Benes F.M. Alterations of neural circuitry within layer II of anterior cingulate cortex in schizophrenia. J. Psychiatr. Res. 33:1999;511-512.
9. Benes F.M. Evidence for altered trisynaptic circuitry in schizophrenic hippocampus. Biol. Psychiatry. 46:1999;589-599.
10. Benes F.M. Emerging principles of altered neural circuitry in schizophrenia. Brain Res. Brain Res. Rev. 31:2000;251-269.
11. Berretta S., Munno D., Benes F.M. Amygdalar activation alters the hippocampal GABA system: 'partial' modeling for postmortem changes in schizophrenia. J. Comp. Neurol. 431:2001;129-138.
12. Best N., Mitchell J., Baimbridge K.G., Wheal H.V. Changes in parvalbumin-immunoreactive neurons in the rat hippocampus following a kainic acid lesion. Neurosci. Lett. 155:1993;1-6.
13. Best N., Mitchell J., Wheal H.V. Ultrastructure of parvalbumin- immunoreactive neurons in the CA1 area of the rat hippocampus following a kainic acid injection. Acta Neuropathol. 87:1994;187-195.
14. Bloom F. Advancing a neurodevelopmental origin for schizophrenia. Arch. Gen. Psychiatry. 50:1994;224-227.
15. Cloninger C.R. The discovery of susceptibility genes for mental disorders. Proc. Natl. Acad. Sci. USA. 99:2002;13365-13367.
16. Cook T., Crutcher K. Intrahippocampal injection of kainic acid produces significant pyramidal cell loss in neonatal rats. Neuroscience. 18:1986;79-92.
17. Cossart R., Dinocourt C., Hirsch J.C., Merchan-Perez A., De Felipe J., Ben-Ari Y., Esclapez M., Bernard C. Dendritic but not GABAergic inhibition is decreased in experimental epilepsy. Nat. Neurosci. 4:2001;52-62.
18. Costa E., Davis J., Grayson D.R., Guidotti A., Pappas G.D., Pesold C. Dendritic spine hypoplasticity and downregulation of reelin and GABAergic tone in schizophrenia vulnerability. Neurobiol. Dis. 8:2001;723-742.
19. Davenport C.J., Brown W.J., Babb T.L. GABAergic neurons are spared after intrahippocampal kainate in the rat. Epilepsy Res. 5:1990;28-42.
20. Dong H.X., Csernansky C.A., Goico B., Csernansky J.G. Hippocampal neurogenesis follows kainic acid-induced apoptosis in neonatal rats. J. Neurosci. 23:2003;1742-1749.
21. Esclapez M., Hirsch J.C., Khazipov R., Ben-Ari Y., Bernard C. Operative GABAergic inhibition in hippocampal CA1 pyramidal neurons in experimental epilepsy. Proc. Natl. Acad. Sci. USA. 94:1997;12151-12156.
22. Frahm G., Draguhn A. GAD and GABA transporter (GAT-1) mRNA expression in the developing rat hippocampus. Dev. Brain Res. 132:2001;1-13.
23. Freund T.F., Buzsaki G. Interneurons of the hippocampus. Hippocampus. 6:1996;347-470.
24. Freedman R., Adams C., Leonard S. The alpha7-nicotinic acetylcholine receptor and the pathology of hippocampal interneurons in schizophrenia. J. Chem. Neuroanat. 20:2000;299-306.
25. Gaiarsa J.L., Khalilov I., Gozlan H., Ben-Ari Y. Morphology of CA3 non-pyramidal cells in the developing rat hippocampus. Brain Res. Dev. Brain Res. 127:2001;157-164.
26. Giardina S.F., Beart P.M. Kainate receptor-mediated apoptosis in primary cultures of cerebellar granule cells is attenuated by mitogen-activated protein and cyclin-dependent kinase inhibitors. Br. J. Pharmacol. 135:2002;1733-1742.
27. Humphrey W.M., Dong H.X., Csernansky C.A., Csernansky J.G. Immediate and delayed hippocampal neuronal loss induced by kainic acid during early postnatal development in the rat. Dev. Brain Res. 137:2002;1-12.
28. Ientile R., Macaione V., Teletta M., Pedale S., Torre V., Macaione S. Apoptosis and necrosis occurring in excitotoxic cell death in isolated chick embryo retina. J. Neurochem. 79:2001;71-78.
29. Jakob H., Beckman H. Prenatal developmental disturbance in the limbic allocortex in schizophrenics. J. Neural Transm. 65:1986;303-326.
30. Johansen F.F., Tonder N., Zimmer J., Baimbridge K.G., Diemer N.H. Short term changes of parvalbumin and calbindin immunoreactivity in rat hippocampus following cerebral ischemia. Neurosci. Lett. 120:1990;171-174.
31. Keverne E.B. GABA-ergic neurons and the neurobiology of schizophrenia and other psychoses. Brain Res. Bull. 48:1999;467-473.
32. Kohler C. Neuronal degeneration after intercerebral injections of excitotoxins. A histological analysis of kainic acid, ibotenic acid and quinolinic acid lesions in the rat brain. Fuxe K., Robert P., Schwarcz R. Excitotoxins. 1984;99-111 Plenum Press, New York.
33. Korhonrn L., Belluardo N., Lindholm D. Regulation of X-chromosome-linked inhibitor of apoptosis protein in kainic acid-induced neuronal death in the rat hippocampus. Mol. Cell Neurosci. 17:2001;364-372.
34. Kosaka T., Katsumaru H., Hama K., Wu J.-Y., Heizmann C.W. GABAergic neurons containing the Ca (+2)-binding protein parvalbumin in the rat hippocampus and dentate gyrus. Brain Res. 419:1987;119-130.
35. Liu W., Liu R., Chun J.T., Bi R., Hoe W., Schreiber S.S., Baudry M. Kainate excitotoxicity in organotypic hippocampal slice cultures: evidence for multiple apoptotic pathways. Brain Res. 916:2001;239-248.
36. Marco P., Sola R.G., Pulido P., Alijarde A., Sanchez S., Ramon S., Cajal Y., DeFelope J. Inhibitory neurons in the human epileptogenic temporal neocortex. Brain Res. 119:1996;1327-1347.
37. McDonald C., Miurray R.M. Early and late environmental risk factors for schizophrenia. Brain Res. Rev. 31:2000;130-137.
38. Miller J.J., Baimbridge K.G. Biochemical and immunohistochemical correlates of kindling-induced epilepsy: role of calcium binding protein. Brain Res. 278:1983;322-326.
39. Mizukami K., Sasaki M., Ishikawa M., Iwakiri M., Hidaka S., Shiraishi H., Iritani S. Immunohistochemical localization of gamma-aminobutyric acid (B) receptor in the hippocampus of subjects with schizophrenia. Neurosci. Lett. 283:2000;101-104.
40. Montgomery E.M.E., Bardgett M.E., Lall B., Csernansky C.A., Csernansky J.G. Delayed neuronal loss after administration of intracerebroventricular kainic acid to preweanling rats. Dev. Brain Res. 112:1999;107-116.
41. Morin F., Beaulieu C., Lacaille J.C. Selective loss of GABA neurons in area CA1 of the rat hippocampus after intraventricular kainate. Epilepsy Res. 32:1998;363-369.
42. Nadler J. Kainic acid as a tool for the study of temporal lobe epilepsy. Life Sci. 29:1981;2031-2042.
43. Paxinos G., Watson C. 2nd Edition The Rat Brain in Stereotaxic Coordinates. 1986;Academic Press, Sydney.
44. Popescu B.O., Oprica M., Sajin M., Stanciu C.L., Bajenaru O., Predescu A., Vidulescu C., Popescu L.M. Dantrolene protects neurons against kainic acid induced apoptosis in vitro and in vivo. J. Cell Mol. Med. 6:2002;555-569.
45. Rozenberg F., Robain O., Jardin L., Ben-Ari Y. Distribution of GABAergic neurons in late fetal and early postnatal rat hippocampus. Dev. Brain Res. 50:1989;177-187.
46. Scharfman H., Goodman J., Sollas A. Granule-like neurons at the hilar/ CA3 border after status epilepticus and their synchrony with area CA3 pyramidal cells: functional implications of seizure-induced neurogenesis. J. Neurosci. 20:2000;6144-6158.
47. Seress L., Ribak C.E. Postnatal development of the light and electron microscopic features of basket cells in the hippocampal dentate gyrus of the rat. Anat. Embryol. 181:1990;547-565.
48. Shetty A.K., Turner D.A. Intracerebroventricular kainic acid administration in adult rat alters hippocampal calbindin and non-phosphorylated neurofilament expression. J. Comp. Neurol. 363:1995;581-599.
49. Shetty A.K., Turner D.A. Glutamic acid decarboxylase-67-positive hippocampal interneurons undergo a permanent reduction in number following kainic acid-induced degeneration of CA3 pyramidal neurons. Exp. Neurol. 169:2001;276-297.
50. Sperk G., Wieser R., Widmann R., Singer E.A. Kainic acid induced seizures: changes in somatostatin, substance P and neurotensin. Neuroscience. 17:1986;1117-1126.
51. Sloviter R.S. Decreased hippocampal inhibition and a selective loss of interneurons in experimental epilepsy. Science. 235:1987;73-76.
52. Todtenkopf M.S., Benes F.M. Distribution of glutamate decarboxylase 65 immunoreactive puncta on pyramidal and nonpyramidal neurons in hippocampus of schizophrenic brain. Synapse. 29:1998;323-332.
53. Tonder N., Kragh J., Bolwig T., Zimmer J. Transient decrease in calbindin immunoreactivity of the rat fascia dentate granule cells after repeated electroconvulsive shocks. Hippocampus. 4:1994;79-84.
54. Toth K., Freund T.F. Calbindin D28k-containing nonpyramidal cells in the rat hippocampus: their immunoreactivity for GABA and projection to the medial septum. Neuroscience. 49:1992;793-805.
55. Waldvogel H.J., Faull R.L.M., Williams M.N., Dragunow M. Differential sensitivity of calbindin and parvalbumin immunoreactive cells in the striatum to excitotoxins. Brain Res. 546:1991;329-335.
56. Weickert C., Weinberger D. A candidate molecule approach to defining developmental pathology in schizophrenia. Schizophren. Bull. 24:1998;303-316.
57. Wolf G., Keilhoff G. Kainate and glutamate neurotoxicity in dependence on the postnatal development with special reference to hippocampal neurons. Brain Res. 316:1984;15-21.